Long-term Clinical Outcomes of Losartan in Patients with Marfan Syndrome

Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial – European Heart Journal

Original Study: Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial – European Heart Journal

Related Commentary on Twitter

Clinical benefit of combined losartan and β-blocker treatment in patients with Marfan syndrome – follow-up of the COMPARE trial https://t.co/lfhrqvacLq@escardio #EHJ #ESC_Young #cardiotwitter @ehj_ed pic.twitter.com/XEHiAfvLOA

— European Society of Cardiology Journals (@ESC_Journals) June 23, 2020